Team 

The Atonco team includes researchers, healthcare professionals, and medical industry experts who are highly experienced in their respective fields and very confident in the future of alpha-immunotherapy.

Jean-François CHATAL,
Chief Medical Officer >>

Sylvain FANIER,
CEO >>

Adrien REYMOND,
RA/QA Director >>

Laurette FISSON, CMC Development Product Director >>

Aurélie MOREAU,
Quality Assurance & Clinical Development Manager >>

Denis BILODEAU,
Clinical Research Director >>

Clément MAYEUR,
Financial and administrative Director >>

Advisors

Jean-Pierre CABOCEL, EMBA, PhD Eng >>
Jacques BARBET, PhD >>
Mario CAMPONE, MD, PhD >>
Jean-Marc LE DOUSSAL, PhD >>